Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 16:15:2949-2956.
doi: 10.2147/JPR.S375874. eCollection 2022.

Epidemiology of Pain Among Patients with Solid Metastatic Cancer During the Last Year of Life

Isha Chaudhry  1 , Mahham Shafiq  1 , Irene Teo  1   2   3 , Semra Ozdemir  1   2 , Chetna Malhotra  1   2 ; COMPASS Study Team
Affiliations

Epidemiology of Pain Among Patients with Solid Metastatic Cancer During the Last Year of Life

Isha Chaudhry et al. J Pain Res. .

Abstract

Background: Despite medical advancements, pain is a major source of suffering at the end of life for patients with a solid metastatic cancer. We aimed to assess the trajectory of pain prevalence, severity, interference, and inadequacy of analgesia during the last year of life.

Methods: We analysed data from the last year of life of 345 decedents from a prospective cohort study of 600 patients with a solid metastatic cancer in Singapore. Patients were surveyed every 3 months and their pain outcomes (prevalence, severity, and interference) and inadequacy of analgesia were analysed. We used mixed-effects regressions to assess the association of pain outcomes with patients' time from death, demographics, and planned or unplanned hospitalisations.

Results: Prevalence of pain was higher in the last 2 months (65%) compared to 11 to 12 months (41%) before death. Pain severity and interference scores (mean ± SD) were also higher in the last month (severity: 2.5±2.6; interference: 2.6±3.0) compared to 12 months before death (severity: 1.4±2.0; interference: 1.4±2.0). At any time during the last year of life, 38% of the patients were prescribed non-steroidal anti-inflammatory drugs, 11% were prescribed weak-opioids and 29% were prescribed strong opioids. These analgesics were prescribed through either oral, topical or injectable route. Pain outcomes were significantly worse (p-value<0.05) for younger patients, those with higher education, and more financial difficulties, while interference was higher after an unplanned hospitalisation in the last month. Females reported higher pain severity score during their last year of life compared to males. For patients reporting moderate to severe pain, inadequacy of analgesia was lower in the last 2 months (43%) compared to 11 to 12 months before death (83%).

Conclusion: Findings highlight the need for greater attention in monitoring and treatment of pain even earlier in the disease trajectory, and increased attention to patients discharged from an unplanned hospitalisation.

Keywords: inadequate analgesia; interference; pain prevalence; severity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest. This work has been presented as a poster at the 12th World Research Congress of the European Association for Palliative Care 2022. The abstract for this poster is published in Abstracts from the 12th World Research Congress of the European Association for Palliative Care. Palliative Medicine. 2022;36(1_suppl):3-122. Isha Chaudhry and Mahham Shafiq are co-first authors.

Figures

Figure 1
Figure 1
Prevalence of pain during the last year of life (N=345). *Pain score>0 on any item of the pain severity score; ^Pain score>3 on any item of the pain severity score.
Figure 2
Figure 2
Adequacy of analgesia during the last year of life in (A) patients with any pain*, (B) patients with moderate to severe pain^. *Pain score>0 on any item of the pain severity score. ^Pain score>3 on any item of the pain severity score.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Hearn J, Higginson I. Cancer pain epidemiology: a systematic review. Cancer Pain Assess Manag. 2003. doi:10.1017/CBO9780511550096.003 - DOI
    1. Van Den Beuken-Van MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016;51(6):1070–1090. e1079. doi:10.1016/j.jpainsymman.2015.12.340 - DOI - PubMed
    1. Greco MT, Roberto A, Corli O, et al. Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol. 2014;32(36):4149–4154. doi:10.1200/JCO.2014.56.0383 - DOI - PubMed
    1. Bennett MI, Eisenberg E, Ahmedzai SH, et al. Standards for the management of cancer‐related pain across Europe—A position paper from the EFIC Task Force on Cancer Pain. Eur J Pain. 2019;23(4):660–668. doi:10.1002/ejp.1346 - DOI - PMC - PubMed
    1. Chapman EJ, Edwards Z, Boland JW, et al. Practice review: evidence-based and effective management of pain in patients with advanced cancer. Palliat Med. 2020;34(4):444–453. doi:10.1177/0269216319896955 - DOI - PubMed